Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Use of epithelial membrane protein 2 [EMP2] targeting agents in treating lung disorders

US Patent 11890340 · Granted Feb 6, 2024

Assignee

Inventors

View full patent text on Google Patents →